Impact of Integrating Chronic Kidney Disease Screening in Occupational Medicine Visits: A Pilot Experience in Senegalese Private Sector Workers
DOI:
https://doi.org/10.12970/2310-984X.2013.01.01.2Keywords:
Chronic kidney disease, epidemiology, population, Senegal.Abstract
Introduction: Chronic kidney disease (CKD) represents an important cause of death and a burden on health systems particularly in low-income countries. To fight this epidemic early detection and primary prevention in at-risk population are recommended but in many African countries, they are inexistent. In this study we assessed the interest of integrating CKD screening in routine medical visits of private sector workers in Dakar. Methods: We conducted a cross-sectional survey in two major private companies who provided regular medical check-up to their employees. Data were collected during annual medical visits. Prevalence of chronic kidney disease (CKD) and additional costs related to renal screening were calculated. Statistical analyses were performed with SPSS 16.0. Results: We included 402 adults (266 men and 136 women) with a mean age of 46.2 ±7.6 (23-75). The mean estimated glomerular filtration rate was 99.8±23.5 ml/min/1.73m² (ranges 35.7-133.5 ml/min/1.73m²). Prevalence of CKD was 22.4% (22.2 % in women versus 22.8 % in men). Albuminuria was present in 5.5% of them. Hypertension was found in 12.1% of patients and prevalence of diabetes was 9.7% and 16.8% for obesity. Introduction of systematic renal screening helped to detect 90% CKD patients who had no clinical symptom even in those with diabetes and/or high blood pressure. Additional cost of the renal tests was estimated to 03 USD per worker yearly. Risk factors associated with low eGFR were age (OR= 1.15, 95% CI= 1.02 - 2.45; p=0.02) and systolic blood pressure (OR= 1.82, 95% CI=1.10 - 4.36; p=0.03). Conclusion: Despite limited sample size, this study demonstrates that opportunistic screening activities in specific socio-professional groups are helpful alternative in absence of national screening and prevention program.References
[1] Couser WG, Remuzzi G, Mendis S, Tonelli M. The contibution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 2011; 80: 1258-70. http://dx.doi.org/10.1038/ki.2011.368
[2] El Nahas AM, Bello AK. Chronic kidney disease: the global challenge. Lancet 2005; 365: 331-40. http://dx.doi.org/10.1016/S0140-6736(05)17789-7
[3] Abegunde D, Mathers CD, Adam T, Ortegon M, Strong K. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 2007; 370: 1929-38. http://dx.doi.org/10.1016/S0140-6736(07)61696-1
[4] Hallan SI, Stevens P. Screening for chronic kidney disease: which strategy? J Nephrol 2010; 23(2): 147-55.
[5] Chen N, Hsu CC, Yamagata K, Langham R. Challenging chronic kidney disease: experience from chronic kidney disease prevention programs in Shanghai, Japan, Taiwan and Australia. Nephrology (Carlton) 2010; 15 (2): 31-6. http://dx.doi.org/10.1111/j.1440-1797.2010.01309.x
[6] Kher V. End-stage renal disease in developing countries. Kidney Int 2002; 62: 350-62. http://dx.doi.org/10.1046/j.1523-1755.2002.00426.x
[7] Perico N, Bravo RF, De Leon FR, Remuzzi G. Screening for chronic kidney disease in emerging countries: feasibility and hurdles. Nephrol Dial Transplant 2009; 24(5): 1355-8. http://dx.doi.org/10.1093/ndt/gfp039
[8] Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Hypertension 2003; 42: 1206-52. http://dx.doi.org/10.1161/01.HYP.0000107251.49515.c2
[9] Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Ann Intern Med 2003; 139(2): 137-47. http://dx.doi.org/10.7326/0003-4819-139-2-200307150- 00013
[10] Eastwood JB, Kerry SM, Plange-Rhule J, Micah FB, Antwi S, Boa FG, Banerjee D, et al. Assessment of GFR by four methods in adults in Ashanti, Ghana: the need for an eGFR equation for lean African populations. Nephrol Dial Transplant 2010; 25(7): 2178-87. http://dx.doi.org/10.1093/ndt/gfp765
[11] Sumaili EK, Krzesinski JM, Cohen EP, Nseka NM. Épidémiologie de la maladie rénale chronique en République Démocratique du Congo: une revue synthétique des études de Kinshasa, la capitale. Nephrol Ther 2010; 6(4): 232-9. http://dx.doi.org/10.1016/j.nephro.2010.03.008
[12] van der Tol A, Van Biesen W, Verbeke F, De Groote G, Vermeiren F, et al. Towards a Rational Screening Strategy for Albuminuria: Results from the Unreferred Renal Insufficiency Trial. PLoS ONE 2010; 5(10): e13328. http://dx.doi.org/10.1371/journal.pone.0013328
[13] Tonelli M. Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006; 17: 2034-47. http://dx.doi.org/10.1681/ASN.2005101085
[14] Vassalotti JA, Fox CH, Becker BN. Risk factors and screening for chronic kidney disease. Adv Chronic Kidney Dis 2010; 17(3): 237-45. http://dx.doi.org/10.1053/j.ackd.2010.03.003
[15] Black C, Sharma P, Scotland G, McCullough K, McGurn D, Robertson L, et al. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Health Technol Assess 2010; 14(21): 1-184.
[16] Levey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global public health problem: approaches and initiatives- a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007; 72: 247-259. http://dx.doi.org/10.1038/sj.ki.5002343
[17] Epping-Jordan JE, Pruitt SD, Bengoa R, Wagner EH. Improving the quality of health care for chronic conditions. Qual Saf Health Care 2004; 13: 299-305. http://dx.doi.org/10.1136/qshc.2004.010744